Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barohn

Showing results (261-270 of 345) with videos related to

Pageof 35
Sort By:
Journal of the Neurological Sciences|October 26, 2001
A placebo-controlled trial of gabapentin in spinal muscular atrophyR G Miller, D H Moore, V Dronsky, et al.
The Lancet. Neurology|October 26, 2017
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyJames F Howard, Kimiaki Utsugisawa, Michael Benatar, et al.
Muscle & Nerve|October 4, 2002
Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravisGil I Wolfe, Richard J Barohn, Barbara M Foster, et al.
Journal of Clinical Neuromuscular Disease|August 23, 2013
Leg amyotrophic diplegia: prevalence and pattern of weakness at US neuromuscular centersMazen M Dimachkie, Iryna M Muzyka, Jonathan S Katz, et al.
Muscle & Nerve|June 2, 2021
Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patientsCarol Milligan, Nazem Atassi, Suma Babu, et al.
Muscle & Nerve|January 31, 2022
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analysesRobert G Miller, Rongzhen Zhang, Paige M Bracci, et al.
Journal of the Neurological Sciences|December 19, 2008
Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathyC L Koski, M Baumgarten, L S Magder, et al.
European Journal of Neurology|February 13, 2023
Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg studyMamatha Pasnoor, Vera Bril, Todd Levine, et al.
Molecular Genetics and Metabolism|October 4, 2012
Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfaAns T van der Ploeg, Richard Barohn, Lisa Carlson, et al.
Muscle & Nerve|May 21, 2019
Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysisGita Ramdharry, Jasper Morrow, Stacie Hudgens, et al.
Pageof 35

Showing results (261-270 of 345) with videos related to

Sort By:
Pageof 35
Journal of the Neurological Sciences|October 26, 2001
A placebo-controlled trial of gabapentin in spinal muscular atrophyR G Miller, D H Moore, V Dronsky, et al.
The Lancet. Neurology|October 26, 2017
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyJames F Howard, Kimiaki Utsugisawa, Michael Benatar, et al.
Muscle & Nerve|October 4, 2002
Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravisGil I Wolfe, Richard J Barohn, Barbara M Foster, et al.
Journal of Clinical Neuromuscular Disease|August 23, 2013
Leg amyotrophic diplegia: prevalence and pattern of weakness at US neuromuscular centersMazen M Dimachkie, Iryna M Muzyka, Jonathan S Katz, et al.
Muscle & Nerve|June 2, 2021
Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patientsCarol Milligan, Nazem Atassi, Suma Babu, et al.
Muscle & Nerve|January 31, 2022
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analysesRobert G Miller, Rongzhen Zhang, Paige M Bracci, et al.
Journal of the Neurological Sciences|December 19, 2008
Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathyC L Koski, M Baumgarten, L S Magder, et al.
European Journal of Neurology|February 13, 2023
Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg studyMamatha Pasnoor, Vera Bril, Todd Levine, et al.
Molecular Genetics and Metabolism|October 4, 2012
Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfaAns T van der Ploeg, Richard Barohn, Lisa Carlson, et al.
Muscle & Nerve|May 21, 2019
Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysisGita Ramdharry, Jasper Morrow, Stacie Hudgens, et al.
Pageof 35